"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Piramal Pharma Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Nandini Piramal
Home : Piramal Ajay G	Book Value: 61.1809785
BSE Code : 543635	Market Cap: 21121.84
NSE Code : PPLPHARMA	P / E : 27.31

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Type	4Qtr	3Qtr	2Qtr	1Qtr
Net Sales	1489.06	1195.81	1127.26	969.88
Other Income	183.69	96.15	201.97	180.92
Total Income	1672.75	1291.96	1329.23	1150.80
Total Expenditure	1251.28	1055.50	1000.19	925.55
Operating Profit	421.47	236.46	329.04	225.25
Interest	19.50	16.84	20.38	23.23
Gross Profit	401.97	219.62	308.66	202.02
Depreciation	70.12	64.69	61.25	59.44
Tax	43.11	19.39	32.55	19.63
Deferred Tax	27.11	6.63	18.53	9.81
Reported Profit After Tax	261.63	128.91	196.33	113.14

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView